Back to Nuveen, LLC

REGN
5 quarters

Position history for Nuveen, LLC's holdings in REGENERON PHARMACEUTICALS

Nuveen, LLC holds 2.1M shares of REGN (REGENERON PHARMACEUTICALS), worth $1.6B as of 2026-Q1. The position was increased (+2.7% shares). REGN represents 0.4% of Nuveen, LLC's portfolio.

Current Value

$1.6B

Current Shares

2.1M

Total Value Change

+$1.3B

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.1M
+2.7%
$1.6B0.4%$766.66
39
2025-Q4
Increased
2M
+71.1%
$1.6B0.4%$773.94
57
2025-Q3
Increased
1.2M
+39.7%
$660.8M0.2%$560.05
50
2025-Q2
Increased
841,549
+55.3%
$441.8M0.1%$519.56
53
2025-Q1
New
542,018
-
$343.8M0.1%$634.66
51

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used